ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 108 filers reported holding ALBIREO PHARMA INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $243,762 | +10.3% | 11,280 | -1.2% | 0.00% | – |
| Q3 2022 | $221,000 | -1.8% | 11,416 | +0.7% | 0.00% | – |
| Q2 2022 | $225,000 | -30.6% | 11,335 | +4.5% | 0.00% | – |
| Q1 2022 | $324,000 | +37.9% | 10,846 | +7.3% | 0.00% | – |
| Q4 2021 | $235,000 | -19.0% | 10,112 | +9.0% | 0.00% | – |
| Q3 2021 | $290,000 | -10.5% | 9,279 | +0.9% | 0.00% | – |
| Q2 2021 | $324,000 | -23.6% | 9,200 | -23.5% | 0.00% | – |
| Q1 2021 | $424,000 | -40.4% | 12,028 | -36.5% | 0.00% | – |
| Q4 2020 | $711,000 | +214.6% | 18,929 | +172.8% | 0.00% | – |
| Q1 2018 | $226,000 | – | 6,939 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 480,000 | $14,318,000 | 9.25% |
| Decheng Capital Management III (Cayman), LLC | 518,342 | $15,462,000 | 4.74% |
| TANG CAPITAL MANAGEMENT LLC | 467,702 | $13,952,000 | 2.79% |
| Birchview Capital, LP | 113,000 | $3,371,000 | 2.43% |
| Privium Fund Management B.V. | 351,805 | $10,494,000 | 2.32% |
| Sio Capital Management, LLC | 144,546 | $4,312,000 | 1.43% |
| Perceptive Advisors | 2,360,139 | $70,403,000 | 1.41% |
| Chicago Capital, LLC | 1,011,744 | $30,180,000 | 1.30% |
| Endurant Capital Management LP | 120,834 | $3,604,000 | 0.95% |
| Nicholas Investment Partners, LP | 439,235 | $13,102,000 | 0.93% |